These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6254862)

  • 1. [Evaluation of hormonal treatment of threatened abortion].
    Skolicki Z
    Folia Med Cracov; 1980; 22(1):137-49. PubMed ID: 6254862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Are progestational agents indicated in threatened abortion?].
    Ned Tijdschr Geneeskd; 1975 Nov; 119(48):1904-5. PubMed ID: 1214899
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synacthene-Retard in mental confusion of aged patients].
    Porte M; Juttner G; Michelangeli J; Krebs BP; Lavagna J; Capdeville C; Darcourt G
    Ann Med Psychol (Paris); 1979; 137(5):481-90. PubMed ID: 228577
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of selected progestational hormones used for the protection of high-risk pregnancy on the clinical course, morphological changes and proliferative activity of the trophoblast].
    Papierowski Z
    Ginekol Pol; 1981 Mar; 52(3):298-303. PubMed ID: 7262593
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prognosis and treatment of threatened abortion. E. Management of the danger of abortion].
    Leng JJ
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):90-4. PubMed ID: 7451888
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of threatened abortion with progestational hormones].
    Montanari GD; Marconato A; Moscolo GF; Montagner P
    Minerva Ginecol; 1969 May; 21(10):683-4. PubMed ID: 5402494
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the problems of progesterone treatment of threatened abortion].
    Steinhoff R
    Dtsch Gesundheitsw; 1967 Aug; 22(32):1502-6. PubMed ID: 5590026
    [No Abstract]   [Full Text] [Related]  

  • 8. [Colpocytological examination in the evaluation of results of hormonal therapy in threatened miscarriage].
    Fedorova MV; Khachaturian EA; Shchepotina NA
    Sov Med; 1973 Oct; 36(10):135-8. PubMed ID: 4789197
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood oxytocinases and phosphatases levels in pregnant women treated with synacthen-depot.
    Klimek R; Krzysiek J; Paradysz A; Stanek J
    Endokrynol Pol; 1978; 29(2):121-9. PubMed ID: 207513
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of a natural progesterone associated with a synthetic progestogen and vitamin E in the treatment of threatened abortion and premature labor].
    Panariello S
    Arch Ostet Ginecol; 1970 Dec; 75(6):492-506. PubMed ID: 5526026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormone therapy in threatened abortion and premature labor].
    Kikawa G
    Josanpu Zasshi; 1976 Dec; 30(12):750-2. PubMed ID: 1051650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term results of treatment with a delayed-action progestational hormone in threatened abortion].
    Scillieri P
    Minerva Ginecol; 1970 Apr; 22(7):413-6. PubMed ID: 5510032
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of imminent abortion with monitoring of the maternal serum HPL level (proceedings)].
    Berle P; Behnke K
    Arch Gynakol; 1977 Jul; 224(1-4):90-1. PubMed ID: 341834
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contractibility of the human uterus and the hormonal situation. Studies on therapy with progesterone in pregnancy].
    Mentasti P; Gagliardi F; Rigon D
    Minerva Ginecol; 1969 May; 21(10):685-7. PubMed ID: 5402495
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of allylestrenol progesterone action on the cervical mucus and the vaginal cytology in threatened abortion, Preliminary report].
    Matute Rafray MM; Ruiz Velasco V; Conde BI; Lozano C
    Ginecol Obstet Mex; 1971 Dec; 30(182):671-9. PubMed ID: 5138659
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of a new progestogen in the therapy of threatened abortion].
    Surace M; Crosignani PG; Campana G
    Minerva Ginecol; 1967 Jun; 19(11):608-12. PubMed ID: 5611221
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of threatened abortion (author's transl)].
    Berle P; Behnke K
    Geburtshilfe Frauenheilkd; 1977 Feb; 37(2):139-42. PubMed ID: 320090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of Cortrosyn Depot in dermatology].
    Aussems J
    Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of abortion with progesterone and etiology of abortion].
    Sakurabayashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1970 Jan; 22(1):69-72. PubMed ID: 5462320
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormonal treatment of spontaneous abortions--our experience].
    Katsulov A; Donchev V
    Akush Ginekol (Sofiia); 1985; 24(6):1-4. PubMed ID: 4091205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.